Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Standard versus high-dose CVVHDF for ICU-related acute renal failure.

Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM.

J Am Soc Nephrol. 2008 Jun;19(6):1233-8. doi: 10.1681/ASN.2007111173. Epub 2008 Mar 12.

2.
3.

Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.

Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY.

Kidney Int. 2006 Oct;70(7):1312-7. Epub 2006 Jul 19.

4.

The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit.

Faulhaber-Walter R, Hafer C, Jahr N, Vahlbruch J, Hoy L, Haller H, Fliser D, Kielstein JT.

Nephrol Dial Transplant. 2009 Jul;24(7):2179-86. doi: 10.1093/ndt/gfp035. Epub 2009 Feb 13.

PMID:
19218540
5.

Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury.

Abe M, Okada K, Suzuki M, Nagura C, Ishihara Y, Fujii Y, Ikeda K, Kaizu K, Matsumoto K.

Artif Organs. 2010 Apr;34(4):331-8. doi: 10.1111/j.1525-1594.2009.00861.x.

PMID:
20420616
6.

Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.

Rauf AA, Long KH, Gajic O, Anderson SS, Swaminathan L, Albright RC.

J Intensive Care Med. 2008 May-Jun;23(3):195-203. doi: 10.1177/0885066608315743.

PMID:
18474503
7.

Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.

Li WX, Chen HD, Wang XW, Zhao S, Chen XK, Zheng Y, Song Y.

Chin Med J (Engl). 2009 May 5;122(9):1020-5.

PMID:
19493435
8.

A prospective study of continuous venovenous hemodiafiltration in critically ill patients with acute renal failure.

Bellomo R, Farmer M, Boyce N.

J Intensive Care Med. 1995 Jul-Aug;10(4):187-92.

PMID:
10155183
10.

Continuous renal replacement therapy: does technique influence electrolyte and bicarbonate control?

Morimatsu H, Uchino S, Bellomo R, Ronco C.

Int J Artif Organs. 2003 Apr;26(4):289-96.

PMID:
12757027
11.

A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.

Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM.

Clin J Am Soc Nephrol. 2006 Jan;1(1):79-87. Epub 2005 Nov 23.

12.

Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury.

Uchino S, Bellomo R, Kellum JA, Morimatsu H, Morgera S, Schetz MR, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-Van Straaten HM, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators Writing Committee.

Int J Artif Organs. 2007 Apr;30(4):281-92.

PMID:
17520564
13.
14.

The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.

Durão MS, Monte JC, Batista MC, Oliveira M, Iizuka IJ, Santos BF, Pereira VG, Cendoroglo M, Santos OF.

Crit Care Med. 2008 Nov;36(11):3024-9. doi: 10.1097/CCM.0b013e31818b9100.

PMID:
18824904
15.

Intensity of renal support in critically ill patients with acute kidney injury.

VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P.

N Engl J Med. 2008 Jul 3;359(1):7-20. doi: 10.1056/NEJMoa0802639. Epub 2008 May 20. Erratum in: N Engl J Med. 2009 Dec 10;361(24):2391.

16.

Intermittent venovenous haemodiafiltration in critically ill patients with acute renal failure.

Van Malderen P, De Rijck L, Vermaut M, Van Leuven G, De Bolle G, Billiouw JM, Lornoy W, Becaus I.

EDTNA ERCA J. 1998 Oct-Dec;24(4):19-20.

PMID:
10222909
17.

High-Dose Versus Conventional-Dose Continuous Venovenous Hemodiafiltration and Patient and Kidney Survival and Cytokine Removal in Sepsis-Associated Acute Kidney Injury: A Randomized Controlled Trial.

Park JT, Lee H, Kee YK, Park S, Oh HJ, Han SH, Joo KW, Lim CS, Kim YS, Kang SW, Yoo TH, Kim DK; HICORES Investigators.

Am J Kidney Dis. 2016 Oct;68(4):599-608. doi: 10.1053/j.ajkd.2016.02.049. Epub 2016 Apr 12.

PMID:
27084247
18.

Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.

Valtonen M, Tiula E, Backman JT, Neuvonen PJ.

J Antimicrob Chemother. 2000 May;45(5):701-4.

PMID:
10797097
19.

Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia.

Agha-Razii M, Amyot SL, Pichette V, Cardinal J, Ouimet D, Leblanc M.

Clin Nephrol. 2000 Jul;54(1):59-63.

PMID:
10939758
20.

Glutamine and other amino acid losses during continuous venovenous hemodiafiltration.

Novák I, Srámek V, Pittrová H, Rusavý P, Lacigová S, Eiselt M, Kohoutková L, Veselá E, Opatrný K Jr.

Artif Organs. 1997 May;21(5):359-63.

PMID:
9129766

Supplemental Content

Support Center